NewEdge Wealth’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $66.4M | Buy |
602,406
+170,165
| +39% | +$18.8M | 1.04% | 15 |
|
|
2025
Q1 | $48.4M | Buy |
432,241
+27,424
| +7% | +$3.07M | 0.88% | 21 |
|
|
2024
Q4 | $37.4M | Buy |
404,817
+30,243
| +8% | +$2.79M | 0.65% | 36 |
|
|
2024
Q3 | $31.4M | Buy |
374,574
+4,087
| +1% | +$343K | 0.57% | 42 |
|
|
2024
Q2 | $25.4M | Sell |
370,487
-6,943
| -2% | -$476K | 0.55% | 47 |
|
|
2024
Q1 | $24.7M | Buy |
377,430
+37,463
| +11% | +$2.45M | 0.55% | 44 |
|
|
2023
Q4 | $27.5M | Buy |
339,967
+27,572
| +9% | +$2.23M | 0.7% | 34 |
|
|
2023
Q3 | $23.4M | Buy |
312,395
+47,137
| +18% | +$3.53M | 0.74% | 32 |
|
|
2023
Q2 | $20.4M | Buy |
265,258
+81,231
| +44% | +$6.26M | 0.68% | 34 |
|
|
2023
Q1 | $15.3M | Buy |
184,027
+97,736
| +113% | +$8.11M | 0.58% | 49 |
|
|
2022
Q4 | $7.41M | Buy |
86,291
+3,874
| +5% | +$333K | 0.32% | 89 |
|
|
2022
Q3 | $5.08M | Sell |
82,417
-23,415
| -22% | -$1.44M | 0.24% | 101 |
|
|
2022
Q2 | $6.54M | Buy |
105,832
+33,126
| +46% | +$2.05M | 0.3% | 87 |
|
|
2022
Q1 | $4.32M | Buy |
72,706
+6,129
| +9% | +$364K | 0.19% | 117 |
|
|
2021
Q4 | $4.83M | Buy |
66,577
+5,011
| +8% | +$364K | 0.2% | 112 |
|
|
2021
Q3 | $4.3M | Buy |
+61,566
| New | +$4.3M | 0.26% | 90 |
|